Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma. Read more about Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma.
Drug development against the hippo pathway in mesothelioma. Read more about Drug development against the hippo pathway in mesothelioma.
Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line? Read more about Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line?
Consolidative radiation therapy for extensive-stage small cell lung cancer. Read more about Consolidative radiation therapy for extensive-stage small cell lung cancer.
An alternative way to initiate Notch1 signaling in non-small cell lung cancer. Read more about An alternative way to initiate Notch1 signaling in non-small cell lung cancer.
International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature. Read more about International trial of adjuvant therapy in high risk stage I non-squamous cell carcinoma identified by a 14-gene prognostic signature.
